메뉴 건너뛰기




Volumn 20, Issue 10, 2015, Pages 1151-1160

Effects of glutamate positive modulators on cognitive deficits in schizophrenia: A systematic review and meta-Analysis of double-blind randomized controlled trials

Author keywords

[No Author keywords available]

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BENZOIC ACID; CARNOSINE; CYCLOSERINE; DEXTRO SERINE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; GLUTAMINE; GLYCINE; GLYCINE TRANSPORTER 1; IONOTROPIC RECEPTOR; KAINIC ACID; KYNURENINE AMINOTRANSFERASE; METABOTROPIC RECEPTOR; MINOCYCLINE; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NOOTROPIC AGENT; ORG 25935; PLACEBO; PREGNENOLONE; SARCOSINE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR AFFECTING AGENT;

EID: 84942550270     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.68     Document Type: Review
Times cited : (83)

References (78)
  • 1
    • 34948816016 scopus 로고    scopus 로고
    • Should schizophrenia be treated as a neurocognitive disorder
    • Goldberg TE, Goldman RS, Burdick KE, Malhotra AK, Lencz T, Patel RC et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatry 2007; 64: 1115-1122.
    • (2007) Arch Gen Psychiatry , vol.64 , pp. 1115-1122
    • Green, M.F.1    Nuechterlein, K.H.2
  • 2
    • 84885476983 scopus 로고    scopus 로고
    • The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study
    • Ayesa-Arriola R, Rodriguez-Sanchez JM, Perez-Iglesias R, Gonzalez-Blanch C, Pardo-Garcia G, Tabares-Seisdedos R et al. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: a 3 year longitudinal study. Psychiatry Res 2013; 209: 302-308.
    • (2013) Psychiatry Res , vol.209 , pp. 302-308
    • Ayesa-Arriola, R.1    Rodriguez-Sanchez, J.M.2    Perez-Iglesias, R.3    Gonzalez-Blanch, C.4    Pardo-Garcia, G.5    Tabares-Seisdedos, R.6
  • 3
    • 0028850552 scopus 로고
    • Glutamate receptor dysfunction and schizophrenia
    • Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52: 998-1007.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 998-1007
    • Olney, J.W.1    Farber, N.B.2
  • 4
    • 0030044715 scopus 로고    scopus 로고
    • The glutamatergic dysfunction hypothesis for schizophrenia
    • Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 1996; 3: 241-253.
    • (1996) Harv Rev Psychiatry , vol.3 , pp. 241-253
    • Coyle, J.T.1
  • 5
    • 0028323167 scopus 로고
    • Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
    • Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214.
    • (1994) Arch Gen Psychiatry , vol.51 , pp. 199-214
    • Krystal, J.H.1    Karper, L.P.2    Seibyl, J.P.3    Freeman, G.K.4    Delaney, R.5    Bremner, J.D.6
  • 7
    • 54049141721 scopus 로고    scopus 로고
    • Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection
    • Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE et al. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 2008; 60: 358-403.
    • (2008) Pharmacol Rev , vol.60 , pp. 358-403
    • Lieberman, J.A.1    Bymaster, F.P.2    Meltzer, H.Y.3    Deutch, A.Y.4    Duncan, G.E.5    Marx, C.E.6
  • 8
    • 0030749913 scopus 로고    scopus 로고
    • Ketamineinduced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
    • Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al. Ketamineinduced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997; 17: 141-150.
    • (1997) Neuropsychopharmacology , vol.17 , pp. 141-150
    • Malhotra, A.K.1    Pinals, D.A.2    Adler, C.M.3    Elman, I.4    Clifton, A.5    Pickar, D.6
  • 10
  • 11
    • 0033377681 scopus 로고    scopus 로고
    • Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia
    • Javitt DC, Liederman E, Cienfuegos A, Shelley AM. Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. Schizophr Bull 1999; 25: 763-775.
    • (1999) Schizophr Bull , vol.25 , pp. 763-775
    • Javitt, D.C.1    Liederman, E.2    Cienfuegos, A.3    Shelley, A.M.4
  • 12
    • 0348047434 scopus 로고    scopus 로고
    • Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: A retrospective analysis
    • Heresco-Levy U, Javitt DC. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophr Res 2004; 66: 89-96.
    • (2004) Schizophr Res , vol.66 , pp. 89-96
    • Heresco-Levy, U.1    Javitt, D.C.2
  • 13
    • 18844441253 scopus 로고    scopus 로고
    • Placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results
    • Diaz P, Bhaskara S, Dursun SM, Double-blind Deakin B. Placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results. J Clin Psychopharmacol 2005; 25: 277-278.
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 277-278
    • Diaz, P.1    Bhaskara, S.2    Dursun, S.M.3    Double-Blind Deakin, B.4
  • 15
    • 84899052394 scopus 로고    scopus 로고
    • Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: A review of old and new targets
    • Ahmed AO, Bhat IA. Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets. CNS Drugs 2014; 28: 301-318.
    • (2014) CNS Drugs , vol.28 , pp. 301-318
    • Ahmed, A.O.1    Bhat, I.A.2
  • 16
    • 77953545879 scopus 로고    scopus 로고
    • A randomized, doubleblind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
    • Lane HY, Lin CH, Huang YJ, Liao CH, Chang YC, Tsai GE. A randomized, doubleblind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia. Int J Neuropsychopharmacol 2010; 13: 451-460.
    • (2010) Int J Neuropsychopharmacol , vol.13 , pp. 451-460
    • Lane, H.Y.1    Lin, C.H.2    Huang, Y.J.3    Liao, C.H.4    Chang, Y.C.5    Tsai, G.E.6
  • 17
    • 84890018607 scopus 로고    scopus 로고
    • Add-on treatment of benzoate for schizophrenia: A randomized, double-blind, placebo-controlled trial of D-Amino acid oxidase inhibitor
    • Lane HY, Lin CH, Green MF, Hellemann G, Huang CC, Chen PW et al. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-Amino acid oxidase inhibitor. JAMA Psychiatry 2013; 70: 1267-1275.
    • (2013) JAMA Psychiatry , vol.70 , pp. 1267-1275
    • Lane, H.Y.1    Lin, C.H.2    Green, M.F.3    Hellemann, G.4    Huang, C.C.5    Chen, P.W.6
  • 18
  • 19
    • 77949447469 scopus 로고    scopus 로고
    • Strategies to enhance N-methyl-D-Aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-Analysis
    • Tsai GE, Lin PY. Strategies to enhance N-methyl-D-Aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-Analysis. Curr Pharm Des 2010; 16: 522-537.
    • (2010) Curr Pharm des , vol.16 , pp. 522-537
    • Tsai, G.E.1    Lin, P.Y.2
  • 20
    • 84883472062 scopus 로고    scopus 로고
    • Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: Meta-Analytical investigation of efficacy
    • Choi KH, Wykes T, Kurtz MM. Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-Analytical investigation of efficacy. Br J Psychiatry 2013; 203: 172-178.
    • (2013) Br J Psychiatry , vol.203 , pp. 172-178
    • Choi, K.H.1    Wykes, T.2    Kurtz, M.M.3
  • 21
    • 42949123365 scopus 로고    scopus 로고
    • Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
    • Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008; 7: 426-437.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 426-437
    • Sanacora, G.1    Zarate, C.A.2    Krystal, J.H.3    Manji, H.K.4
  • 22
    • 55049131112 scopus 로고    scopus 로고
    • Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors
    • Imbesi M, Uz T, Manev R, Sharma RP, Manev H. Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors. Neurosci Lett 2008; 447: 134-137.
    • (2008) Neurosci Lett , vol.447 , pp. 134-137
    • Imbesi, M.1    Uz, T.2    Manev, R.3    Sharma, R.P.4    Manev, H.5
  • 24
    • 0030745226 scopus 로고    scopus 로고
    • Co-localization of carnosine and glutamate in photoreceptors and bipolar cells of the frog retina
    • Panzanelli P, Cantino D, Sassoe-Pognetto M. Co-localization of carnosine and glutamate in photoreceptors and bipolar cells of the frog retina. Brain Res 1997; 758: 143-152.
    • (1997) Brain Res , vol.758 , pp. 143-152
    • Panzanelli, P.1    Cantino, D.2    Sassoe-Pognetto, M.3
  • 25
    • 0032210918 scopus 로고    scopus 로고
    • Carnosine and beta-Alanine release is stimulated by glutamatergic receptors in cultured rat oligodendrocytes
    • Bakardjiev A. Carnosine and beta-Alanine release is stimulated by glutamatergic receptors in cultured rat oligodendrocytes. Glia 1998; 24: 346-351.
    • (1998) Glia , vol.24 , pp. 346-351
    • Bakardjiev, A.1
  • 26
    • 0032950897 scopus 로고    scopus 로고
    • Redox mechanisms at the glutamate synapse and their significance: A review
    • Smythies J. Redox mechanisms at the glutamate synapse and their significance: a review. Eur J Pharmacol 1999; 370: 1-7.
    • (1999) Eur J Pharmacol , vol.370 , pp. 1-7
    • Smythies, J.1
  • 27
    • 0032870428 scopus 로고    scopus 로고
    • Hydroxyl radical scavenging by carnosine and Cu(II)-carnosine complexes: A pulse-radiolysis and spectroscopic study
    • Tamba M, Torreggiani A. Hydroxyl radical scavenging by carnosine and Cu(II)-carnosine complexes: a pulse-radiolysis and spectroscopic study. Int J Radiat Biol 1999; 75: 1177-1188.
    • (1999) Int J Radiat Biol , vol.75 , pp. 1177-1188
    • Tamba, M.1    Torreggiani, A.2
  • 28
    • 84906228003 scopus 로고    scopus 로고
    • Targeting of NMDA receptors in new treatments for schizophrenia
    • Hashimoto K. Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin Ther Targets 2014; 18: 1049-1063.
    • (2014) Expert Opin Ther Targets , vol.18 , pp. 1049-1063
    • Hashimoto, K.1
  • 29
    • 67449123074 scopus 로고    scopus 로고
    • Proof-ofconcept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
    • Marx CE, Keefe RS, Buchanan RW, Hamer RM, Kilts JD, Bradford DW et al. Proof-ofconcept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology 2009; 34: 1885-1903.
    • (2009) Neuropsychopharmacology , vol.34 , pp. 1885-1903
    • Marx, C.E.1    Keefe, R.S.2    Buchanan, R.W.3    Hamer, R.M.4    Kilts, J.D.5    Bradford, D.W.6
  • 30
    • 84907469449 scopus 로고    scopus 로고
    • A role for picomolar concentrations of pregnenolone sulfate in synaptic activity-dependent Ca2 + signaling and CREB activation
    • Smith CC, Martin SC, Sugunan K, Russek SJ, Gibbs TT, Farb DH. A role for picomolar concentrations of pregnenolone sulfate in synaptic activity-dependent Ca2 + signaling and CREB activation. Mol Pharmacol 2014; 86: 390-398.
    • (2014) Mol Pharmacol , vol.86 , pp. 390-398
    • Smith, C.C.1    Martin, S.C.2    Sugunan, K.3    Russek, S.J.4    Gibbs, T.T.5    Farb, D.H.6
  • 31
    • 84925548115 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement
    • Group P
    • Moher D, Liberati A, Tetzlaff J, Altman DG. Group P. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012.
    • (2009) J Clin Epidemiol , vol.62 , pp. 1006-1012
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 32
    • 4444220908 scopus 로고    scopus 로고
    • Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria
    • Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 2004; 56: 301-307.
    • (2004) Biol Psychiatry , vol.56 , pp. 301-307
    • Green, M.F.1    Nuechterlein, K.H.2    Gold, J.M.3    Barch, D.M.4    Cohen, J.5    Essock, S.6
  • 34
    • 0023921695 scopus 로고
    • Effects of keto acid supplements on renal function and histology in azotemic rats fed high-protein diets
    • Hirschberg R, Cohen AH, Kopple JD. Effects of keto acid supplements on renal function and histology in azotemic rats fed high-protein diets. Am J Nephrol 1988; 8: 50-56.
    • (1988) Am J Nephrol , vol.8 , pp. 50-56
    • Hirschberg, R.1    Cohen, A.H.2    Kopple, J.D.3
  • 36
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-Analysis detected by a simple, graphical test
    • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 37
    • 0033934949 scopus 로고    scopus 로고
    • Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-Analysis
    • Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-Analysis. Biometrics 2000; 56: 455-463.
    • (2000) Biometrics , vol.56 , pp. 455-463
    • Duval, S.1    Tweedie, R.2
  • 38
    • 79960201543 scopus 로고    scopus 로고
    • Effects of body position, imaging plane, and observer on computed tomographic measurements of the lumbosacral intervertebral foraminal area in dogs
    • Higgins BM, Cripps PJ, Baker M, Moore L, Penrose FE, McConnell JF. Effects of body position, imaging plane, and observer on computed tomographic measurements of the lumbosacral intervertebral foraminal area in dogs. Am J Vet Res 2011; 72: 905-917.
    • (2011) Am J Vet Res , vol.72 , pp. 905-917
    • Higgins, B.M.1    Cripps, P.J.2    Baker, M.3    Moore, L.4    Penrose, F.E.5    McConnell, J.F.6
  • 39
  • 40
    • 84895818899 scopus 로고    scopus 로고
    • Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
    • Liu F, Guo X, Wu R, Ou J, Zheng Y, Zhang B et al. Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial. Schizophr Res 2014; 153: 169-176.
    • (2014) Schizophr Res , vol.153 , pp. 169-176
    • Liu, F.1    Guo, X.2    Wu, R.3    Ou, J.4    Zheng, Y.5    Zhang, B.6
  • 41
    • 84896404591 scopus 로고    scopus 로고
    • The selective glycine uptake inhibitor Org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: Results from the GIANT trial
    • Schoemaker JH, Jansen WT, Schipper J, Szegedi A. The selective glycine uptake inhibitor Org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial. Journal of Clinical Psychopharmacology 2014; 34: 190-198.
    • (2014) Journal of Clinical Psychopharmacology , vol.34 , pp. 190-198
    • Schoemaker, J.H.1    Jansen, W.T.2    Schipper, J.3    Szegedi, A.4
  • 42
    • 84872486732 scopus 로고    scopus 로고
    • Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: An international collaborative pilot study
    • D'Souza DC, Radhakrishnan R, Perry E, Bhakta S, Singh NM, Yadav R et al. Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study. Neuropsychopharmacology 2013; 38: 492-503.
    • (2013) Neuropsychopharmacology , vol.38 , pp. 492-503
    • D'Souza, D.C.1    Radhakrishnan, R.2    Perry, E.3    Bhakta, S.4    Singh, N.M.5    Yadav, R.6
  • 43
    • 84869879025 scopus 로고    scopus 로고
    • A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia
    • Chengappa KN, Turkin SR, DeSanti S, Bowie CR, Brar JS, Schlicht PJ et al. A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia. Schizophr Res 2012; 142: 145-152.
    • (2012) Schizophr Res , vol.142 , pp. 145-152
    • Chengappa, K.N.1    Turkin, S.R.2    DeSanti, S.3    Bowie, C.R.4    Brar, J.S.5    Schlicht, P.J.6
  • 44
    • 84863550158 scopus 로고    scopus 로고
    • A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia
    • Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA et al. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. J Clin Psychiatry 2012; 73: e728-e734.
    • (2012) J Clin Psychiatry , vol.73 , pp. e728-e734
    • Weiser, M.1    Heresco-Levy, U.2    Davidson, M.3    Javitt, D.C.4    Werbeloff, N.5    Gershon, A.A.6
  • 45
    • 77649112679 scopus 로고    scopus 로고
    • A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia
    • Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 2010; 71: 138-149.
    • (2010) J Clin Psychiatry , vol.71 , pp. 138-149
    • Levkovitz, Y.1    Mendlovich, S.2    Riwkes, S.3    Braw, Y.4    Levkovitch-Verbin, H.5    Gal, G.6
  • 46
    • 48749112603 scopus 로고    scopus 로고
    • N-Acetyl cysteine as a glutathione precursor for schizophrenia-A double-blind, randomized, placebocontrolled trial
    • Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I et al. N-Acetyl cysteine as a glutathione precursor for schizophrenia-A double-blind, randomized, placebocontrolled trial. Biol Psychiatry 2008; 64: 361-368.
    • (2008) Biol Psychiatry , vol.64 , pp. 361-368
    • Berk, M.1    Copolov, D.2    Dean, O.3    Lu, K.4    Jeavons, S.5    Schapkaitz, I.6
  • 47
    • 35748969317 scopus 로고    scopus 로고
    • The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
    • Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP et al. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 2007; 164: 1593-1602.
    • (2007) Am J Psychiatry , vol.164 , pp. 1593-1602
    • Buchanan, R.W.1    Javitt, D.C.2    Marder, S.R.3    Schooler, N.R.4    Gold, J.M.5    McMahon, R.P.6
  • 49
    • 0034796599 scopus 로고    scopus 로고
    • A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia
    • Goff DC, Leahy L, Berman I, Posever T, Herz L, Leon AC et al. A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. J Clin Psychopharmacol 2001; 21: 484-487.
    • (2001) J Clin Psychopharmacol , vol.21 , pp. 484-487
    • Goff, D.C.1    Leahy, L.2    Berman, I.3    Posever, T.4    Herz, L.5    Leon, A.C.6
  • 50
    • 0032902238 scopus 로고    scopus 로고
    • A placebocontrolled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
    • Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA et al. A placebocontrolled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 1999; 56: 21-27.
    • (1999) Arch Gen Psychiatry , vol.56 , pp. 21-27
    • Goff, D.C.1    Tsai, G.2    Levitt, J.3    Amico, E.4    Manoach, D.5    Schoenfeld, D.A.6
  • 52
    • 0032403626 scopus 로고    scopus 로고
    • D-serine added to antipsychotics for the treatment of schizophrenia
    • Tsai G, Yang P, Chung LC, Lange N, Coyle JT. D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 1998; 44: 1081-1089.
    • (1998) Biol Psychiatry , vol.44 , pp. 1081-1089
    • Tsai, G.1    Yang, P.2    Chung, L.C.3    Lange, N.4    Coyle, J.T.5
  • 55
    • 84868680041 scopus 로고    scopus 로고
    • No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophrenia
    • Ohnuma T, Sakai Y, Maeshima H, Higa M, Hanzawa R, Kitazawa M et al. No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophrenia. Int J Psychiatry Med 2012; 44: 17-27.
    • (2012) Int J Psychiatry Med , vol.44 , pp. 17-27
    • Ohnuma, T.1    Sakai, Y.2    Maeshima, H.3    Higa, M.4    Hanzawa, R.5    Kitazawa, M.6
  • 56
    • 78650034460 scopus 로고    scopus 로고
    • Glutamate as a marker of cognitive function in schizophrenia: A proton spectroscopic imaging study at 4 Tesla
    • Bustillo JR, Chen H, Gasparovic C, Mullins P, Caprihan A, Qualls C et al. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol Psychiatry 2011; 69: 19-27.
    • (2011) Biol Psychiatry , vol.69 , pp. 19-27
    • Bustillo, J.R.1    Chen, H.2    Gasparovic, C.3    Mullins, P.4    Caprihan, A.5    Qualls, C.6
  • 57
    • 84860743254 scopus 로고    scopus 로고
    • Elevated prefrontal cortex gamma-Aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy
    • Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X et al. Elevated prefrontal cortex gamma-Aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2012; 69: 449-459.
    • (2012) Arch Gen Psychiatry , vol.69 , pp. 449-459
    • Kegeles, L.S.1    Mao, X.2    Stanford, A.D.3    Girgis, R.4    Ojeil, N.5    Xu, X.6
  • 58
    • 84890084726 scopus 로고    scopus 로고
    • Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia
    • Kraguljac NV, White DM, Reid MA, Lahti AC. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry 2013; 70: 1294-1302.
    • (2013) JAMA Psychiatry , vol.70 , pp. 1294-1302
    • Kraguljac, N.V.1    White, D.M.2    Reid, M.A.3    Lahti, A.C.4
  • 59
    • 34047185227 scopus 로고    scopus 로고
    • Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study
    • Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res 2007; 41: 625-634.
    • (2007) J Psychiatr Res , vol.41 , pp. 625-634
    • Ohrmann, P.1    Siegmund, A.2    Suslow, T.3    Pedersen, A.4    Spitzberg, K.5    Kersting, A.6
  • 62
    • 71849110853 scopus 로고    scopus 로고
    • Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study
    • Shirayama Y, Obata T, Matsuzawa D, Nonaka H, Kanazawa Y, Yoshitome E et al. Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage 2010; 49: 2783-2790.
    • (2010) Neuroimage , vol.49 , pp. 2783-2790
    • Shirayama, Y.1    Obata, T.2    Matsuzawa, D.3    Nonaka, H.4    Kanazawa, Y.5    Yoshitome, E.6
  • 64
    • 14844321950 scopus 로고    scopus 로고
    • Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up
    • Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005; 162: 495-506.
    • (2005) Am J Psychiatry , vol.162 , pp. 495-506
    • Milev, P.1    Ho, B.C.2    Arndt, S.3    Andreasen, N.C.4
  • 65
    • 84895894183 scopus 로고    scopus 로고
    • Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia
    • Torgalsboen AK, Mohn C, Rishovd Rund B. Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia. Psychiatry Res 2014; 216: 1-5.
    • (2014) Psychiatry Res , vol.216 , pp. 1-5
    • Torgalsboen, A.K.1    Mohn, C.2    Rishovd Rund, B.3
  • 66
    • 84887009409 scopus 로고    scopus 로고
    • AMPARs and synaptic plasticity: The last 25 years
    • Huganir RL, Nicoll RA. AMPARs and synaptic plasticity: the last 25 years. Neuron 2013; 80: 704-717.
    • (2013) Neuron , vol.80 , pp. 704-717
    • Huganir, R.L.1    Nicoll, R.A.2
  • 67
    • 84929193210 scopus 로고    scopus 로고
    • Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia
    • MacDonald ML, Ding Y, Newman J, Hemby S, Penzes P, Lewis DA et al. Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia. Biol Psychiatry 2015; 77: 959-968.
    • (2015) Biol Psychiatry , vol.77 , pp. 959-968
    • MacDonald, M.L.1    Ding, Y.2    Newman, J.3    Hemby, S.4    Penzes, P.5    Lewis, D.A.6
  • 68
    • 36749009127 scopus 로고    scopus 로고
    • Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated withmoderate cognitive impairment in humans
    • Wu Y, Arai AC, Rumbaugh G, Srivastava AK, Turner G, Hayashi T et al. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated withmoderate cognitive impairment in humans. Proc Natl Acad Sci USA 2007; 104: 18163-18168.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 18163-18168
    • Wu, Y.1    Arai, A.C.2    Rumbaugh, G.3    Srivastava, A.K.4    Turner, G.5    Hayashi, T.6
  • 69
    • 0029592136 scopus 로고
    • NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia
    • Olney JW, Farber NB. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 1995; 13: 335-345.
    • (1995) Neuropsychopharmacology , vol.13 , pp. 335-345
    • Olney, J.W.1    Farber, N.B.2
  • 70
    • 0042343859 scopus 로고    scopus 로고
    • Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine
    • Takahata R, Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 2003; 28: 1117-1124.
    • (2003) Neuropsychopharmacology , vol.28 , pp. 1117-1124
    • Takahata, R.1    Moghaddam, B.2
  • 71
    • 0030900732 scopus 로고    scopus 로고
    • Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
    • Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997; 17: 2921-2927.
    • (1997) J Neurosci , vol.17 , pp. 2921-2927
    • Moghaddam, B.1    Adams, B.2    Verma, A.3    Daly, D.4
  • 72
    • 2942537881 scopus 로고    scopus 로고
    • NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
    • Jackson ME, Homayoun H, Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA 2004; 101: 8467-8472.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 8467-8472
    • Jackson, M.E.1    Homayoun, H.2    Moghaddam, B.3
  • 73
    • 84881313914 scopus 로고    scopus 로고
    • Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
    • Hashimoto K, Malchow B, Falkai P, Schmitt A. Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci 2013; 263: 367-377.
    • (2013) Eur Arch Psychiatry Clin Neurosci , vol.263 , pp. 367-377
    • Hashimoto, K.1    Malchow, B.2    Falkai, P.3    Schmitt, A.4
  • 74
    • 0016682243 scopus 로고
    • D-serine nephrotoxicity. The nature of proteinuria, glucosuria, and aminoaciduria in acute tubular necrosis
    • Carone FA, Ganote CE. D-serine nephrotoxicity. The nature of proteinuria, glucosuria, and aminoaciduria in acute tubular necrosis. Arch Pathol 1975; 99: 658-662.
    • (1975) Arch Pathol , vol.99 , pp. 658-662
    • Carone, F.A.1    Ganote, C.E.2
  • 77
    • 84857082115 scopus 로고    scopus 로고
    • Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
    • Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M. Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Br J Pharmacol 2012; 165: 1543-1555.
    • (2012) Br J Pharmacol , vol.165 , pp. 1543-1555
    • Tanahashi, S.1    Yamamura, S.2    Nakagawa, M.3    Motomura, E.4    Okada, M.5
  • 78
    • 8744278883 scopus 로고    scopus 로고
    • Glutamate as a therapeutic target in psychiatric disorders
    • Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 2004; 9: 979.
    • (2004) Mol Psychiatry , vol.9 , pp. 979
    • Javitt, D.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.